| 摘要 |
The present invention relates to a pharmaceutical composition comprising as active ingredient a compound selected among somatostatin or one of its analogs, diazoxide or one of its analogs, cyclothiazide or one of its analogs and metformin, for the treatment of syndrome X of Reaven (also called "Hyper Insulinemia syndrome" or "The Deadly Quartet"). |
